France - Research and experimental development services - Functional characterisation of therapeutic antibodies

This tender covers the functional characterisation of therapeutic antibodies for cancer pathologies. The service includes testing antibody specificity in recognising tumour antigens or cells and assessing their ability to deplete tumour cells in vitro using cellular models and in vivo using murine models. The buyer is a French entity involved in the broader RHU SPRINT project. The work is considered urgent because services cannot extend beyond 2029. Small businesses with relevant research and development expertise may bid if they can deliver the required biological testing.

Description

3 open tenders right now

• IT systems consulting and technical advice - Organisation of elections and decision-making by electronic means at Universite Paris Cite and the Institut de Physique du Globe de Paris (IPGP) 20 Oct 2026 · 27 days left
• Repair and maintenance services of fire extinguishing installations - Maintenance of fire safety systems and natural smoke ventilation at Université Paris Cité 23 Oct 2026 · 30 days left
• Purchase of a 25kN to 40kN fatigue testing machine capable of running cycles at a frequency of 1Hz 30 Oct 2026 · 37 days left

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

1. 5 Aug 2026 Act now
   • Submission deadline: Moved 1 day EARLIER: now August 25, 2026, 00:00
   • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Market context

Avg. open tender · Research & development

€3,264,378

532 open across Europe right now

Buyer track record on Aperlena

9 notices tracked · 0 awarded